Glucose Biosensor Market Size Worth USD 20.06 Billion 2030| A CAGR...

Glucose Biosensor Market Size Worth USD 20.06 Billion 2030| A CAGR of 7.9%

Posted 2023-10-31 09:58:05

Market Trends: The global market for glucose biosensors, which was valued at USD 10.20 billion in 2021, is projected to experience a 7.9% compound annual growth rate (CAGR) in revenue throughout the forecast period. Key drivers for this growth include the rising number of diabetic patients, significant advancements in medical technology, increased consumer spending power, and notable progress in biosensor technology. According to the International Diabetes Federation (IDF), the global diabetic population reached approximately 537 million in 2021, and this number is projected to increase to 643 million by 2030. Notably, technological advancements in wearable sensors and digital healthcare have made noninvasive monitoring of blood glucose levels possible, revolutionizing the efficiency of glucose control.

The introduction of wearable, noninvasive devices that employ various physical principles, such as glucose oxidase, fluorescence, or skin dielectric characteristics, to provide real-time glucose measurements every 1–5 minutes has transformed glucose monitoring.

Get a sample copy of the Glucose Biosensor Market report: https://www.reportsanddata.com/download-free-sample/5460

The growing demand for self-monitoring devices is another significant driver of market revenue. Biosensors, particularly in portable devices, have gained popularity due to increased demand for self-monitoring equipment. These biosensors are now available in small, minimally invasive medical devices that can accurately measure a patient's blood glucose levels. While blood glucose monitoring remains the gold standard for detecting glucose levels, alternative body fluids such as sweat, saliva, tears, and interstitial fluids can also be used for glucose detection.

Technological advancements in biosensor devices for monitoring blood glucose levels are also contributing to market growth. For instance, on April 5, 2022, GlucoModicum introduced a peer-reviewed study demonstrating the successful integration of its Magnetohydrodynamic (MHD) technology platform with an amperometric biosensor to create a Continuous non-invasive Glucose Monitoring (CGM) system. Additionally, Abbott introduced the Libre Sense Glucose Sport Biosensor in 2020, designed for athletes to continuously monitor their blood sugar levels.

Market Dynamics: Driving Factor: Glucose monitoring sensors offer accurate and precise data, making them crucial for managing glucose levels. Continuous Glucose Monitoring (CGM) devices provide a comprehensive view of glycemia, collecting data continuously and calculating the present rate of glucose change based on historical data. For example, on June 5, 2022, Abbott's FreeStyle Libre 3 system achieved a sub-8% overall Mean Absolute Relative Difference (MARD), a measure of sensor accuracy.

Restraint: While glucose biosensors are valuable, alternative methods for monitoring glucose levels exist, including blood sample collection from veins and transdermal Reverse Iontophoresis (RI). These alternative methods offer accurate measurements and can indirectly infer patient health data, which may hinder the growth of glucose biosensors in the market.

Key Takeaways: Product Type Outlook: The global glucose biosensor market is divided into Continuous Glucose Monitoring (CGM) and Self-Monitoring Blood Glucose (SMBG). CGM is expected to account for the largest share of revenue during the forecast period due to its ability to precisely monitor blood glucose levels and provide real-time results. SMBG is also expected to grow moderately, driven by increasing consumer awareness and the prevalence of hyperglycemic disorders.

Technology Type Outlook: The market is categorized into electrochemical, optical, piezoelectric, and other technology types. Electrochemical biosensors are in high demand due to their portability, cost-effectiveness, and ability to analyze various substances. Optical biosensors offer high specificity and low production costs, while piezoelectric biosensors are known for their compactness and sensitivity.

Regional Outlook: In 2021, North America accounted for the largest share of the market revenue, driven by technological advancements in glucose biosensors and a significant diabetic population. Europe was the second-largest market, with the UK leading in revenue share. The Asia Pacific region is experiencing moderate growth due to improving healthcare facilities and awareness about early diagnosis.

Competitive Landscape: The market is moderately consolidated, with major companies engaging in product development and strategic alliances. Key players include Abbott, Dexcom Inc., F. Hoffmann-La Roche Ltd., Sanofi, Bayer AG, GlySens Incorporated, Trividia Health, Inc., Medtronic, LifeScan IP Holdings, LLC., and Senseonics.

Recent Developments:

Roche launched the Accu-Chek Instant system, a "connected" Blood Glucose Monitoring system, to support personalized diabetes management.
Medtronic received FDA approval for the Android version of its Guardian Connect Continuous Glucose Monitoring system.

Market Scope:

Market Size in 2021: USD 10.20 Billion
Expected CAGR (2021-2030): 7.9%
Revenue Forecast in 2030: USD 20.06 Billion
Historical Data: 2019-2020
Forecast Period: 2022-2030
Segments: Product Type, Technology Type, End-Use, and Region

Explore Trending Reports:

Ambulatory Care Service Market-https://www.globenewswire.com/news-release/2019/08/07/1898487/0/en/Ambulatory-Care-Service-Market-To-Reach-USD-113-06-Billion-By-2026-Reports-And-Data.html

Surgical Instruments Market-https://www.globenewswire.com/news-release/2019/11/19/1949660/0/en/Surgical-Instruments-Market-To-Reach-USD-21-52-Billion-By-2026-Reports-And-Data.html

Ultrasound Market-https://www.globenewswire.com/news-release/2020/01/14/1970523/0/en/Ultrasound-Market-To-Reach-USD-10-44-Billion-By-2027-Reports-And-Data.html

Lithium Therapy Market-https://www.globenewswire.com/news-release/2020/03/09/1997330/0/en/Lithium-Therapy-Market-To-Reach-USD-128-6-Million-By-2027-Reports-and-Data.html

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/5460

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports